Clinical & Pharma

Urban Dog Bites: Epidemiology and Public Awareness on Rabies Management
Clinical & Pharma Urban Dog Bites: Epidemiology and Public Awareness on Rabies Management

Urban dog bites represent a prevalent yet often overlooked public health issue with significant implications for rabies transmission. The issue is far from trivial, given that rabies, a deadly zoonotic disease transmitted primarily through dog bites, can have severe consequences if not managed

Is More Funding the Solution to Western Cape’s Healthcare Crisis?
Clinical & Pharma Is More Funding the Solution to Western Cape’s Healthcare Crisis?

The healthcare system in the Western Cape (WC), South Africa, has recently come under intense scrutiny following a viral video from Helen Joseph Hospital that exposed severe deficiencies within the facility. Even though a significant 36% of the province’s budget is allocated towards healthcare,

Should Clinical Trials Return Data to Participants for Ethical Reasons?
Clinical & Pharma Should Clinical Trials Return Data to Participants for Ethical Reasons?

Returning individual clinical trial data to patients has become a pressing ethical and practical issue. As trials grow more complex and participant investment increases, the drive to honor their contributions and expectations through returning data aligns with key ethical principles rooted in

How Will New Funding Guidelines Improve New Zealand's Healthcare?
Clinical & Pharma How Will New Funding Guidelines Improve New Zealand's Healthcare?

In a significant move aimed at enhancing New Zealand’s public health landscape, Health Minister Dr. Shane Reti has announced new guidelines for the Health Research Council (HRC) of New Zealand. These guidelines emphasize a targeted approach, ensuring that research funding aligns closely with

How Will J&J's 340B Policy Changes Impact Hospitals and Patients?
Clinical & Pharma How Will J&J's 340B Policy Changes Impact Hospitals and Patients?

Johnson & Johnson (J&J) recently announced a significant shift in their approach to the 340B drug discount program, aiming to change how discounts are offered for crucial medications. This policy adjustment is set to take effect on October 15, 2024, and has raised considerable concerns among

Transforming Elderly Care: Evaluating Pre-Post Surgery Geriatric Assessments
Clinical & Pharma Transforming Elderly Care: Evaluating Pre-Post Surgery Geriatric Assessments

In recent years, the focus on perioperative care for older patients has become a critical concern, particularly for those undergoing elective hip and knee replacements. This concern is emphasized in Australia, where a significant population of elderly individuals requires such surgeries. A

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later